Table 1
Open in new tab

Baseline characteristics of the patients

ParametersNaTS group (n = 30)Saline group (n = 30)P-value
Males, %56.770.00.211
Age (years), mean ± SD63.8 ± 13.264.1 ± 9.70.938
Body weight (kg), mean ± SD71.5 ± 9.172.0 ± 7.50.713
Active/previous smokers, n790.230
Dialysis vintage (months), mean ± SD104.4 ± 80.5103.7 ± 75.10.972
Diabetes (main disease or comorbidity), %23.320.00.500
ESRD assumed due to, %––0.210
 Diabetes mellitus10.010.0–
 Hypertension50.056.7
 Glomerulonephritis20.03.3
 Tubulointerstitial renal disease13.316.7
 ADPKD05.0
 Other6.73.3
Dialysate calcium (mEq/L), mean ± SD1.35 ± 0.31.36 ± 0.40.845
Patients receiving PO4− binders, %20230.932
Intake of elemental calcium from PO4− binders (g/day), mean ± SD1.36 ± 0.611.38 ± 0.540.541
Patients receiving calcitriol, %14130.593
Calcitriol (µg/week), mean ± SD1.75 ± 1.331.77 ± 1.360.491
ParametersNaTS group (n = 30)Saline group (n = 30)P-value
Males, %56.770.00.211
Age (years), mean ± SD63.8 ± 13.264.1 ± 9.70.938
Body weight (kg), mean ± SD71.5 ± 9.172.0 ± 7.50.713
Active/previous smokers, n790.230
Dialysis vintage (months), mean ± SD104.4 ± 80.5103.7 ± 75.10.972
Diabetes (main disease or comorbidity), %23.320.00.500
ESRD assumed due to, %––0.210
 Diabetes mellitus10.010.0–
 Hypertension50.056.7
 Glomerulonephritis20.03.3
 Tubulointerstitial renal disease13.316.7
 ADPKD05.0
 Other6.73.3
Dialysate calcium (mEq/L), mean ± SD1.35 ± 0.31.36 ± 0.40.845
Patients receiving PO4− binders, %20230.932
Intake of elemental calcium from PO4− binders (g/day), mean ± SD1.36 ± 0.611.38 ± 0.540.541
Patients receiving calcitriol, %14130.593
Calcitriol (µg/week), mean ± SD1.75 ± 1.331.77 ± 1.360.491

ADPKD, autosomal dominant polycystic kidney disease; SD, standard deviation.

Table 1
Open in new tab

Baseline characteristics of the patients

ParametersNaTS group (n = 30)Saline group (n = 30)P-value
Males, %56.770.00.211
Age (years), mean ± SD63.8 ± 13.264.1 ± 9.70.938
Body weight (kg), mean ± SD71.5 ± 9.172.0 ± 7.50.713
Active/previous smokers, n790.230
Dialysis vintage (months), mean ± SD104.4 ± 80.5103.7 ± 75.10.972
Diabetes (main disease or comorbidity), %23.320.00.500
ESRD assumed due to, %––0.210
 Diabetes mellitus10.010.0–
 Hypertension50.056.7
 Glomerulonephritis20.03.3
 Tubulointerstitial renal disease13.316.7
 ADPKD05.0
 Other6.73.3
Dialysate calcium (mEq/L), mean ± SD1.35 ± 0.31.36 ± 0.40.845
Patients receiving PO4− binders, %20230.932
Intake of elemental calcium from PO4− binders (g/day), mean ± SD1.36 ± 0.611.38 ± 0.540.541
Patients receiving calcitriol, %14130.593
Calcitriol (µg/week), mean ± SD1.75 ± 1.331.77 ± 1.360.491
ParametersNaTS group (n = 30)Saline group (n = 30)P-value
Males, %56.770.00.211
Age (years), mean ± SD63.8 ± 13.264.1 ± 9.70.938
Body weight (kg), mean ± SD71.5 ± 9.172.0 ± 7.50.713
Active/previous smokers, n790.230
Dialysis vintage (months), mean ± SD104.4 ± 80.5103.7 ± 75.10.972
Diabetes (main disease or comorbidity), %23.320.00.500
ESRD assumed due to, %––0.210
 Diabetes mellitus10.010.0–
 Hypertension50.056.7
 Glomerulonephritis20.03.3
 Tubulointerstitial renal disease13.316.7
 ADPKD05.0
 Other6.73.3
Dialysate calcium (mEq/L), mean ± SD1.35 ± 0.31.36 ± 0.40.845
Patients receiving PO4− binders, %20230.932
Intake of elemental calcium from PO4− binders (g/day), mean ± SD1.36 ± 0.611.38 ± 0.540.541
Patients receiving calcitriol, %14130.593
Calcitriol (µg/week), mean ± SD1.75 ± 1.331.77 ± 1.360.491

ADPKD, autosomal dominant polycystic kidney disease; SD, standard deviation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close